PD
Prof. Dr. Petra Reinke
CMO & Head of Clinical Development & Cell Therapy Manufacturing
TCBalance BiopharmaceuticalsTCBalance Biopharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Treg Cell Therapy Platform | Autoimmune diseases, Transplant rejection, GvHD, Hyperinflammation | Pre-clinical |
Leadership Team at TCBalance Biopharmaceuticals
PD
Prof. Dr. Olaf Weber
CEO
PD
Prof. Dr. Hans-Dieter Volk
CSO
DD
Dr. Dimitrios L. Wagner
Head of Research & Preclinical Development